Kerydin OverviewTavaborole, sold under the brand name Kerydin, is a topical antifungal medication for the treatment of onychomycosis, a fungal infection of the nail and nail bed. Tavaborole began phase III clinical trials in December 2010 and was approved by the US FDA in July 2014. The medication inhibits an essential fungal enzyme, leucyl-tRNA synthetase, that is required for protein synthesis. The inhibition of protein synthesis leads to termination of cell growth and...
Read more Kerydin Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Tavaborole
Recent Kerydin Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Solution: 5%
NDC Database Records for Kerydin: (2 results)Sorted by National Drug Code
- 10337-905 Kerydin 43.5 mg/ml Topical Solution by Pharmaderm, a Division of Fougera Pharmaceuticals Inc.
- 55724-111 Kerydin 43.5 mg/ml Topical Solution by Anacor Pharmaceuticals, Inc